Literature DB >> 22555652

Multifunctional hybrid materials for combined photo and chemotherapy of cancer.

Pablo Botella1, Ilida Ortega, Manuel Quesada, Roque F Madrigal, Carlos Muniesa, Antonio Fimia, Eduardo Fernández, Avelino Corma.   

Abstract

Combined chemo and photothermal therapy in in vitro testing has been achieved by means of multifunctional nanoparticles formed by plasmonic gold nanoclusters with a protecting shell of porous silica that contains an antitumor drug. We propose a therapeutic nanoplatform that associates the optical activity of small gold nanoparticles aggregates with the cytotoxic activity of 20(S)-camptothecin simultaneously released for the efficient destruction of cancer cells. For this purpose, a method was used for the controlled assembly of gold nanoparticles into stable clusters with a tailored absorption cross-section in the vis/NIR spectrum, which involves aggregation in alkaline medium of 15 nm diameter gold colloids protected with a thin silica layer. Clusters were further encapsulated in an ordered homogeneous mesoporous silica coating that provides biocompatibility and stability in physiological fluids. After internalization in 42-MG-BA human glioma cells, these protected gold nanoclusters were able to produce effective photothermolysis under femtosecond pulse laser irradiation of 790 nm. Cell death occurred by combination of a thermal mechanism and mechanical disruption of the membrane cell due to induced generation of micrometer-scale bubbles by vaporizing the water inside the channels of the mesoporous silica coating. Moreover, the incorporation of 20(S)-camptothecin within the pores of the external shell, which was released during the process, provoked significant cell death increase. This therapeutic model could be of interest for application in the treatment and suppression of non-solid tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555652     DOI: 10.1039/c2dt30381g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  9 in total

1.  Synthesis and solution isomerization of water-soluble Au9 nanoclusters prepared by nuclearity conversion of [Au11(PPh3)8Cl2]Cl.

Authors:  William Ndugire; Mingdi Yan
Journal:  Nanoscale       Date:  2021-10-14       Impact factor: 8.307

Review 2.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 3.  The Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature Review.

Authors:  Reza Fekrazad; Nafiseh Naghdi; Hanieh Nokhbatolfoghahaei; Hossein Bagheri
Journal:  J Lasers Med Sci       Date:  2016-03-27

4.  Near infrared light mediated photochemotherapy for efficiently treating deep orthotopic tumors guided by ultrasound imaging.

Authors:  Zuhua Wang; Shaoyan Xuan; Wenqi Qiu; Jiang Zhu; Xiaomeng Guo; Wei Li; Hanbo Zhang; Xiuliang Zhu; Yong-Zhong Du; Jian You
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Remotely Triggered Nano-Theranostics For Cancer Applications.

Authors:  Alexandra Sneider; Derek VanDyke; Shailee Paliwal; Prakash Rai
Journal:  Nanotheranostics       Date:  2017

Review 6.  Shell isolated nanoparticle enhanced Raman spectroscopy for mechanistic investigation of electrochemical reactions.

Authors:  Andi Haryanto; Chan Woo Lee
Journal:  Nano Converg       Date:  2022-02-14

7.  Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma.

Authors:  Nicole F Bonan; Debbie K Ledezma; Matthew A Tovar; Preethi B Balakrishnan; Rohan Fernandes
Journal:  Nanomaterials (Basel)       Date:  2022-08-01       Impact factor: 5.719

Review 8.  Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.

Authors:  Amir Barzegar Behrooz; Zahra Talaie; Amir Syahir
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

Review 9.  Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release.

Authors:  Avelino Corma; Pablo Botella; Eva Rivero-Buceta
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.